Neurological / SeizureTablet

    Carbidopa And Levodopa

    carbidopa and levodopa

    Carbidopa and levodopa extended-release tablets, USP are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

    Form

    Tablet

    Uses

    1

    Side effects

    2

    Category

    Neurological

    01

    What is Carbidopa And Levodopa used for?

    • Carbidopa and levodopa extended-release tablets, USP are indicated in the treatment of Parkinson's d
    02

    carbidopa and levodopa side effects

    Common side effects of carbidopa and levodopa include:

    Levodopa tablets or carbidopa
    Levodopa extended-release tablets
    CommonModerateLess common
    03

    carbidopa and levodopa warnings & precautions

    • When patients are receiving levodopa without a decarboxylase inhibitor, levodopa must be discontinued at least twelve hours before carbidopa and levod
    • In order to reduce adverse reactions, it is necessary to individualize therapy.
    • See DOSAGE AND ADMINISTRATION section before initiating therapy.

    Loading FDA data…

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Carbidopa And Levodopa in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.